Mebendazole effectively overcomes imatinib resistance by dual-targeting BCR/ABL oncoprotein and β-tubulin in chronic myeloid leukemia cells.
Saved in:
| Title: | Mebendazole effectively overcomes imatinib resistance by dual-targeting BCR/ABL oncoprotein and β-tubulin in chronic myeloid leukemia cells. |
|---|---|
| Authors: | Li Yang1, Zhuanyun Du1, Yuhang Peng1, Wenyao Zhang1, Wenli Feng1, Ying Yuan2 yuanying@hospital.cqmu.edu.cn |
| Source: | Korean Journal of Physiology & Pharmacology. Jan2025, Vol. 29 Issue 1, p67-81. 15p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
